9 documents found, page 1 of 1

Sort by Issue Date

The Portuguese version of Rhinitis and Asthma Patient's Perspective (RAPP): Val...

Todo-Bom, Ana; Braido, F.; Molinengo, G.; Loureiro, C.; Canonica, G. W.; Baiardini, I.

Background: Allergic rhinitis (AR) and asthma are two common chronic diseases that often coexist. There is a need for a validated tool to evaluate HRQoL of Portuguese speakers with asthma and/or rhinitis patients in clinical practice. Objectives: To adapt and validate RhinAsthma Patient Perspective (RAPP) in Portuguese. Methods: The RAPP questionnaire was translated into Portuguese. Asthmatics with comorbiditie...


Allergic Rhinitis and its Impact on Asthma (ARIA) Phase 4 (2018): Change manage...

Bousquet, Jean; Bindslev-Jensen, Carsten; Baiardini, I.; Braido, F.; Bachert, C.; Mota-Pinto, A.

Allergic Rhinitis and its Impact on Asthma (ARIA) has evolved from a guideline by using the best approach to integrated care pathways using mobile technology in patients with allergic rhinitis (AR) and asthma multimorbidity. The proposed next phase of ARIA is change management, with the aim of providing an active and healthy life to patients with rhinitis and to those with asthma multimorbidity across the lifec...


Erratum to: Scaling up strategies of the chronic respiratory disease programme ...

Bousquet, J; Farrell, J; Crooks, G; Hellings, P; Bel, E H; Bewick, M; Chavannes, N H; de Sousa, J Correia; Cruz, A A; Haahtela, T; Joos, G; Khaltaev, N

[This corrects the article DOI: 10.1186/s13601-016-0116-9.].


ARIA 2016: Care pathways implementing emerging technologies for predictive medi...

Bousquet, J.; Hellings, P. W.; Agache, I.; Bedbrook, A.; Bachert, C.; Bergmann, K. C.; Bewick, M.; Bindslev-Jensen, C.; Bosnic-Anticevitch, S.

The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA-disseminated and im...


Scaling up strategies of the chronic respiratory disease programme of the Europ...

Bousquet, J.; Farrell, J.; Crooks, G.; Hellings, P.; Bel, E. H.; Bewick, M.; Chavannes, N. H.; de Sousa, J. Correia; Cruz, A. A.; Haahtela, T.; Joos, G.

Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respiratory disease action plan includes (1) AIRWAYS integrated care pathways (ICPs), (2) the joint initiative between the Reference site MACVIA-LR (Contre les MAladies C...


ARIA 2016: care pathways implementing emerging technologies for predictive medi...

Bousquet, J.; Hellings, P. W.; Agache, I.; Bedbrook, A.; Bachert, C.; Bergmann, K. C.; Bewick, M.; Bindslev-Jensen, C.; Bosnic-Anticevitch, S.

The Allergic Rhinitis and its Impact on Asthma (ARIA) initiative commenced during a World Health Organization workshop in 1999. The initial goals were (1) to propose a new allergic rhinitis classification, (2) to promote the concept of multi-morbidity in asthma and rhinitis and (3) to develop guidelines with all stakeholders that could be used globally for all countries and populations. ARIA-disseminated and im...


Recommendations for assessing patient-reported outcomes and health-related qual...

Baiardini, I.; Braido, F.; Bindslev-Jensen, C.; Bousquet, P. J.; Brzoza, Z.; Canonica, G. W.; Compalati, E.; Fiocchi, A.; Fokkens, W.

The aim of this Global Allergy and Asthma European Network (GA2LEN) consensus report is to provide recommendations and suggestions for assessing patient-reported outcomes (PROs) including health-related quality of life in patients with urticaria. We recommend that PROs should be used both in clinical trials and routine practice for the evaluation of urticaria patients. We suggest that PROs should be considered ...


Specific recommendations for PROs and HRQoL assessment in allergic rhinitis and...

Braido, F.; Bousquet, P. J.; Brzoza, Z.; Canonica, G. W.; Compalati, E.; Fiocchi, A.; Fokkens, W.; Gerth van Wijk, R.; La Grutta, S.; Lombardi, C.

The GA2LEN taskforce on Patient-Reported Outcomes (PROs) and Health-Related Quality of Life (HRQoL) published in 2009 a position paper concerning PROS and HRQoL assessment in clinical trials on allergy. Because of the specificity of this topic in asthma and rhinitis, specific recommendations are needed. The aim of this position paper is to define PROs and their meaning in asthma and rhinitis research, explore t...


Recommendations for assessing Patient-Reported Outcomes and Health-Related qual...

Baiardini, I.; Bousquet, P. J.; Brzoza, Z.; Canonica, G. W.; Compalati, E.; Fiocchi, A.; Fokkens, W.; Gerth van Wijk, R.; La Grutta, S.; Lombardi, C.

The aim of this GA2LEN consensus report is to provide recommendations for Patient-Reported Outcomes evaluation in clinical trials for allergic diseases, which constitute a global health problem in terms of physical, psychological, economic and social impact. During the last 40 years PROs have gained large consideration and use in the scientific community, in order to gain a better understanding of patients’ sub...


9 Results

Queried text

Refine Results

Author





















Date







Document Type


Access rights


Resource



Subject